Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone furoate aerosol for eosinophilic esophagitis (phase II, randomized, placebo-controlled)
2012-005842-39Phase 2Terminated
- Sponsor
- Norra Älvsborgs Länssjukhus
- Start
- Nov 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in eosinophilic esophagitis (EoE) comparing Mometasone furoate aerosol (Nasonex) with Placebo aerosol (2 arms). Primary endpoint: Primary dysphagia endpoint. Started Nov 2013; status: terminated.
02
Drugs
mometasone
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on 2012-005842-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005842-39.